Rise in diabetic ketoacidosis during the COVID-19 pandemic: several questions remain

Lancet Diabetes Endocrinol. 2022 Nov;10(11):763-765. doi: 10.1016/S2213-8587(22)00272-8. Epub 2022 Oct 3.

Author

Shivani Misra¹

Affiliation

¹ Division of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, London, UK; Department of Diabetes, Endocrinology and Metabolism, Imperial College Healthcare NHS Trust, London, UK. Electronic address: s.misra@imperial.ac.uk.

No abstract available

Publication types

Comment

MeSH terms

COVID-19*
Diabetes Mellitus, Type 1*
Diabetic Ketoacidosis* / epidemiology
Humans
Pandemics
SARS-CoV-2